이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!
Globus Medical 관리
관리 기준 확인 4/4
현재 CEO에 대한 정보가 충분하지 않습니다.
주요 정보
Dan Scavilla
최고 경영자
US$4.6m
총 보상
| CEO 급여 비율 | 10.2% |
| CEO 임기 | 2.2yrs |
| CEO 소유권 | n/a |
| 경영진 평균 재임 기간 | 5.2yrs |
| 이사회 평균 재임 기간 | 5.1yrs |
최근 관리 업데이트
Recent updates
An Intrinsic Calculation For Globus Medical, Inc. (NYSE:GMED) Suggests It's 42% Undervalued
Apr 08
Globus Medical (NYSE:GMED) Seems To Use Debt Rather Sparingly
Mar 20Globus Medical Q4: Greater Dis-Synergies Hold Back The Stock
Feb 27Is Now An Opportune Moment To Examine Globus Medical, Inc. (NYSE:GMED)?
Feb 09Globus Medical, Inc.'s (NYSE:GMED) Price In Tune With Earnings
Jan 17Globus Medical: Merger Overhang Lingering
Nov 27Does Globus Medical (NYSE:GMED) Have A Healthy Balance Sheet?
Nov 14Should You Investigate Globus Medical, Inc. (NYSE:GMED) At US$46.27?
Oct 27Globus Medical: Almost Having My Back
Sep 13Globus Medical: Slightly Too Pricey Right Now
Aug 07Globus Medical: Robotics Demand Ratcheting Higher, Reiterate Buy
Jul 18Should You Think About Buying Globus Medical, Inc. (NYSE:GMED) Now?
Jul 11Here's Why We Think Globus Medical (NYSE:GMED) Is Well Worth Watching
Jun 18Globus Medical (NYSE:GMED) Will Be Hoping To Turn Its Returns On Capital Around
Apr 09What Is Globus Medical, Inc.'s (NYSE:GMED) Share Price Doing?
Mar 22Do Globus Medical's (NYSE:GMED) Earnings Warrant Your Attention?
Feb 24Globus Medical Q4 2022 Earnings Preview
Feb 20Globus Medical: An Impressive Long-Term Revenue Growth Play
Jan 08Is It Too Late To Consider Buying Globus Medical, Inc. (NYSE:GMED)?
Dec 22Globus Medical (NYSE:GMED) Will Want To Turn Around Its Return Trends
Dec 01Globus Medical Non-GAAP EPS of $0.50 misses by $0.02, revenue of $254.15M in-line
Nov 08A Look At The Fair Value Of Globus Medical, Inc. (NYSE:GMED)
Oct 15Globus Medical: Compelling Long-Term Value On Offer, Buy Thesis Intact
Sep 02Globus Medical (NYSE:GMED) Will Be Hoping To Turn Its Returns On Capital Around
Sep 02Is Globus Medical, Inc. (NYSE:GMED) Potentially Undervalued?
Aug 11Globus Medical: Low Rates Sensitivity, Seeking 26% Return Objective
Jun 05Globus Medical (NYSE:GMED) May Have Issues Allocating Its Capital
May 24Is It Too Late To Consider Buying Globus Medical, Inc. (NYSE:GMED)?
May 06An Intrinsic Calculation For Globus Medical, Inc. (NYSE:GMED) Suggests It's 22% Undervalued
Mar 14Globus Medical Continues To Flex Its Innovation Muscles To Drive Share Growth
Mar 01Globus Medical's (NYSE:GMED) Performance Is Even Better Than Its Earnings Suggest
Feb 24Returns On Capital At Globus Medical (NYSE:GMED) Paint A Concerning Picture
Feb 08Should You Think About Buying Globus Medical, Inc. (NYSE:GMED) Now?
Jan 21CEO 보상 분석
| 날짜 | 총 보상 | 급여 | 회사 수익 |
|---|---|---|---|
| Mar 31 2024 | n/a | n/a | US$67m |
| Dec 31 2023 | US$5m | US$464k | US$123m |
| Sep 30 2023 | n/a | n/a | US$158m |
| Jun 30 2023 | n/a | n/a | US$204m |
| Mar 31 2023 | n/a | n/a | US$201m |
| Dec 31 2022 | US$4m | US$437k | US$190m |
| Sep 30 2022 | n/a | n/a | US$155m |
| Jun 30 2022 | n/a | n/a | US$155m |
| Mar 31 2022 | n/a | n/a | US$142m |
| Dec 31 2021 | US$2m | US$396k | US$149m |
| Sep 30 2021 | n/a | n/a | US$187m |
| Jun 30 2021 | n/a | n/a | US$184m |
| Mar 31 2021 | n/a | n/a | US$122m |
| Dec 31 2020 | US$2m | US$384k | US$102m |
| Sep 30 2020 | n/a | n/a | US$95m |
| Jun 30 2020 | n/a | n/a | US$89m |
| Mar 31 2020 | n/a | n/a | US$148m |
| Dec 31 2019 | US$2m | US$366k | US$155m |
| Sep 30 2019 | n/a | n/a | US$146m |
| Jun 30 2019 | n/a | n/a | US$143m |
| Mar 31 2019 | n/a | n/a | US$150m |
| Dec 31 2018 | US$2m | US$355k | US$156m |
| Sep 30 2018 | n/a | n/a | US$144m |
| Jun 30 2018 | n/a | n/a | US$134m |
| Mar 31 2018 | n/a | n/a | US$118m |
| Dec 31 2017 | US$1m | US$345k | US$107m |
보상 대 시장: Dan 의 총 보상 ($USD 4.56M ) US 시장에서 비슷한 규모의 회사에 대한 평균보다 낮습니다( $USD 8.45M ).
보상과 수익: Dan 의 보상은 지난 한 해 동안 회사 성과와 일치했습니다.
CEO
Dan Scavilla (59 yo)
2.2yrs
테뉴어
US$4,564,374
보상
Mr. Daniel T. Scavilla, also known as Dan, serves as President and Chief Executive Officer at Globus Medical, Inc. since April 21, 2022 and serves as its Director since April 2022. He had been Executive Vi...
리더십 팀
| 이름 | 위치 | 테뉴어 | 보상 | 소유권 |
|---|---|---|---|---|
| Co-Founder & Executive Chairman | 21.4yrs | US$3.22m | 16.48% $ 1.5b | |
| President | 2.2yrs | US$4.56m | 데이터 없음 | |
| CFO & COO | 4.8yrs | US$2.06m | 0% $ 0 | |
| Senior VP | 5.5yrs | US$1.64m | 0% $ 0 | |
| Senior Vice President of Business Development & Investor Relations | no data | 데이터 없음 | 데이터 없음 |
5.2yrs
평균 재임 기간
57yo
평균 연령
경험이 풍부한 관리: GMED 의 관리팀은 노련하고 경험 (평균 재직 기간 5.2 년)입니다.
이사회 구성원
| 이름 | 위치 | 테뉴어 | 보상 | 소유권 |
|---|---|---|---|---|
| Co-Founder & Executive Chairman | 21.4yrs | US$3.22m | 16.48% $ 1.5b | |
| President | 2.2yrs | US$4.56m | 데이터 없음 | |
| Independent Director | 12.9yrs | US$490.69k | 0.017% $ 1.5m | |
| Independent Director | less than a year | US$276.27k | 0.012% $ 1.0m | |
| Independent Director | 5.1yrs | US$470.69k | 0% $ 0 | |
| Independent Director | 8.8yrs | US$478.19k | 0% $ 0 | |
| Independent Director | less than a year | US$278.15k | 0.018% $ 1.6m | |
| Independent Director | 4.5yrs | US$470.69k | 0.0015% $ 133.9k | |
| Independent Director | 21.3yrs | US$468.19k | 0.57% $ 51.7m | |
| Independent Director | less than a year | US$278.77k | 0.013% $ 1.2m | |
| Independent Director | 13.2yrs | US$478.19k | 0% $ 0 |
5.1yrs
평균 재임 기간
62yo
평균 연령
경험이 풍부한 이사회: GMED 의 이사회는 경험(평균 재직 기간 5.1 년)으로 간주됩니다.